Randomized trial of three IVIg doses for treating chronic inflammatory demyelinating polyneuropathy

Intravenous immunoglobulin treatment for chronic inflammatory demyelinating polyneuropathy usually starts with a 2.0 g/kg induction dose followed by 1.0 g/kg maintenance doses every 3 weeks. No dose-ranging studies with intravenous immunoglobulin maintenance therapy have been published. The Progress...

Descripción completa

Detalles Bibliográficos
Autores principales: Cornblath, David R, van Doorn, Pieter A, Hartung, Hans-Peter, Merkies, Ingemar S J, Katzberg, Hans D, Hinterberger, Doris, Clodi, Elisabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050528/
https://www.ncbi.nlm.nih.gov/pubmed/35038723
http://dx.doi.org/10.1093/brain/awab422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9050528/
https://www.ncbi.nlm.nih.gov/pubmed/35038723
http://dx.doi.org/10.1093/brain/awab422

Ejemplares similares